We regularly feature in industry articles, white papers and at events. This page is the perfect page for all things Merxin related. See our press releases, latest tweet, LinkedIn updates and all the latest news all in one place.
Stay up to date with the latest news and information from Merxin.
We publish our news and updates on LinkedIn where we have a company page and publish our blog, here is the link to our blog. We are also on Twitter using our handle @MRXdevices.
We regularly attend industry events. Please note due to COVID - 19 travel restrictions, no Merxin employees are currently travelling to any conferences.
— Merxin Ltd (@MRXdevices) October 15, 2021
FDA confirms the substitutability of MRX004. MRX004 is available for licencing for tiotropium/olodaterol SMI. Be in touch!https://t.co/Qkg7LctjUc pic.twitter.com/32uhXTAuxc
— Merxin Ltd (@MRXdevices) July 30, 2021
It is a Match!
— Merxin Ltd (@MRXdevices) July 26, 2021
MRX006, Merxin dual cavity for triple therapy multidose DPI, is a match for fluticasone / vilanterol / umeclidinium DPI.https://t.co/2aBDamaOcM pic.twitter.com/ff2ZorOsZ7
